Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

EnVivo Pharmaceuticals

Mission: to discover and develop small-molecule therapeutics for disorders of the central nervous system (CNS), specifically neurodegenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and Spinocerebellar Ataxias.About UsEnVivo Pharmaceuticals was founded in 2001 and currently has 37 FTEs. EnVivo has raised ~$38M in two funding rounds, $14.9M Series A in October 2002 and $23M Series B in September 2004. Investors include scientific founders, Fidelity Bioscience Group, BBBC Investor Group that includes Baylor College of Medicine, and CoGene BioTech Ventures.


Contact Details:
480 Arsenal Street, Building 1
Watertown
Massachusetts
02472
United States of America
Tel:617-225-4250
Fax:617-225-4267
Email:info@envivopharma.com
WWW:

www.envivopharma.com/




Loading...

Press Releases on EnVivo Pharmaceuticals:

BioPortfolio Logo
EnVivo to Share Results of its EVP-6124 Phase Ib/IIa Trial at The International Conference on Alzheimer's Disease 7th July, 2009 EnVivo Pharmaceuticals
WATERTOWN, Mass., July 7 /PRNewswire/ -- WHAT: EnVivo Pharmaceuticals to share results from its Ib/IIa trial in Alzheimer's disease patients with its
EnVivo and Mitsubishi Tanabe Enter License Agreement on EVP-6124 in Japan, Korea, Taiwan and Other Asian Countries 1st April, 2009 EnVivo Pharmaceuticals
WATERTOWN, Mass., April 1, /PRNewswire/ -- EnVivo Pharmaceuticals today announced an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) for the development and commercialization of its lead

BioNews Results for EnVivo Pharmaceuticals:

Windhover Expands Its List of Top Projects to Watch
Genetic Engineering News:  Oct 30 2009 5:53PM Matching: envivo pharmaceuticals
Windhover Expands Its List of Top Projects to Watch
Sys-Con Canada:  Oct 30 2009 5:38PM Matching: envivo pharmaceuticals
Windhover Expands Its List of Top Projects to Watch
Street Insider:  Oct 30 2009 5:29PM Matching: envivo pharmaceuticals
Windhover Expands Its List of Top Projects to Watch
Street Insider:  Oct 30 2009 5:28PM Matching: envivo pharmaceuticals
Windhover Expands Its List of Top Projects to Watch
PR inside:  Oct 30 2009 5:26PM Matching: envivo pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more EnVivo Pharmaceuticals news.

EnVivo Pharmaceuticals Clinical Trials:

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 263 times since April 2007, the link to the organisation's website has been followed 40 times

Recent Search Terms used to find this page: Envivo Pharma | EnVivo Pharmaceuticals | EnVivo Pharmaceuticals | envivo pharma investors | envivo | envivo pharmaceuticals founded 2004 | .

Search for more companies in Watertown

Search for more companies in Massachusetts



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for EnVivo Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.